GLP1R and obesity due to melanocortin 4 receptor deficiency: CONCLUSION: GLP-1 receptor agonists significantly reduce OSA severity, promote substantial weight loss, and lower systolic and diastolic blood pressure in patients with obstructive sleep apnea and obesity.